Sympathetic and parasympathetic interaction in vascular and secretory control of salivary glands in anaesthetised dogs

Autonomic Neuroscience: Basic and Clinical

Volumn 84, Issue 1-2, 2000, Pages 50-57

  McCloskey, Matthew J D ^a   Potter, Erica K ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Blood flow; NPY; Saliva

Indexed keywords

GR 231118; METHACHOLINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PENTOBARBITAL;

ADRENERGIC ACTIVITY; ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOG; ELECTROSTIMULATION; FEMALE; MALE; NERVE STIMULATION; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; SALIVARY GLAND; SALIVATION; TISSUE BLOOD FLOW; VASODILATATION;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC FIBERS; ANESTHESIA, INTRAVENOUS; ANIMAL; DOGS; FEMALE; MALE; NEUROPEPTIDE Y; PARASYMPATHETIC FIBERS, POSTGANGLIONIC; PEPTIDES, CYCLIC; RECEPTORS, NEUROPEPTIDE Y; SALIVARY GLANDS; SALIVATION; SUPPORT, NON-U.S. GOV'T; VASODILATION;

EID: 0034735738     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-0702(00)00181-8     Document Type: Article

References (41)

1. Bernard C. De l'influence de deux ordres de nrfs qui déterminent les variations de couleur du sang veineux dans les organes glandulaires. CR Acad. Sci. 47:1858;245-253.
2. Bloom S.R., Edwards A.V. Vasoactive intestinal peptide in relation to atropine resistant vasodilatation in the submaxillary gland of the cat. J. Physiol. 300:1980;41-53.
3. Bloom S.R., Edwards A.V., Garrett J.R. Effects of stimulating the sympathetic innervation in bursts on submandibular and secretory function in cats. J. Physiol. 393:1987;91-106.
4. Coppes R.P., Smit J., Geursten A.M., Roffel A.F., Dahlof C., Doods H.N., Zaagsma J. Heterogeneity of prejunctional neuropeptide Y receptors inhibiting noradrenaline overflow in the portal vein of freely moving rats. Eur. J. Pharmacol. 261:1994;311-316.
5. Daniels A.J., Matthews J.E., Slepetis R.J., Jansen M., Viveros O.H., Tadepalli A., Harrington W., Heyer D., Landavazo A., Leban J.J. High-affinity neuropeptide Y receptor antagonists. Proc. Natl. Acad. Sci. USA. 92:1995;9067-9071.
6. Doods H.N., Krause J. Different neuropeptide Y receptor subtypes in rat and rabbit vas deferens. Eur. J. Pharmacol. 204:1991;101-103.
7. Edwards A.V., Garrett J.R. Nitric oxide-related vasodilator responses to parasympathetic stimulation of the submandibular gland in the cat. J. Physiol. 464:1993;379-392.
8. Edwards A.V., Garrett J.R., Proctor G.B. Secretory interactions between the sympathetic and parasympathetic innervations of the submandibular gland in the anaesthetized cat. Exp. Physiol. 82:1997;697-708.
9. Ekstrom J. Autonomic control of salivary secretion. Proc. Finn. Dent. Soc. 85:1991;323-331.
10. Emmelin N., Gjorstrup P. Secretory responses to sympathetic stimulation of the cat's salivary glands in the state of 'resting secretion'. Quart. J. Exp. Physiol. 60:1975;325-332.
11. Gardner T.D., Potter E.K. Dependence of non-adrenergic inhibition of cardiac vagal action on peak frequency of sympathetic stimulation in the dog. J. Physiol. 405:1988;115-122.
12. Garrett J.R., Suleiman A.M., Anderson L.C., Proctor G.B. Secretory responses in granular ducts and acini of submandibular glands in vivo to parasympathetic or sympathetic nerve stimulation in rats. Cell Tissue Res. 264:1991;117-126.
13. Garrett J.R., Zhang X.S., Proctor G.B., Anderson L.C. Sequential secretion of rat submandibular kallikrein and peroxidase during intermittent stimulation. J. Auton. Nerv. Syst. 61:1996;26-30.
14. 125I-labeled peptide YY binding sites in the rat brain. Neurochem. Int. 21:1992;45-67.
15. Gjorstrup P. Effects of sympathetic nerve stimulation in the presence of a slow parasympathetic secretion in the parotid and submaxillary glands of the rabbit. Acta Physiol. Scand. 101:1977;211-218.
16. Gjorstrup P. Blood flow and secretion in the submaxillary gland of the rabbit during stimulation of the autonomic nerves. Acta Physiol. Scand. 115:1982;91-95.
17. 1 receptor antagonist. J. Pharmacol. Exp. Ther. 275:1995;1261-1266.
18. Kilborn M.J., Potter E.K., McCloskey D.I. Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides. Regul. Pept. 12:1985;155-161.
19. Lacroix J.S., Ulman L.G., Potter E.K. Sympathetic and parasympathetic interaction in vascular control of the nasal mucosa in anaesthetized cats. J. Physiol. 480:1994;325-331.
20. Liddell E.G.T., Sherrington C. Salivary secretion; air embolism; expansion of lungs by aspiration. Liddell E.G.T., Sherrington C. Mammalian Physiology, A Course of Practical Exercises. 1929;69-75 Clarendon Press, London.
21. Ludwig C. Neue versuch uber die belhulf der nerven zu der speichel-sekretion. Mitteilung. Naturforsch. Gesellsch. (Zürich). 53-54:1898;210-239.
22. Lundberg J.M., Anggard A., Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. I. VIP release. Acta Physiol. Scand. 113:1981;317-327.
23. Lundberg J.M., Hedlund B., Bartfai T. Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature. 295:1982;147-149.
24. Lundberg J.M., Hua X.Y., Franco-Cereceda A. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol. Scand. 121:1984;325-332.
25. Lundberg J.M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol. Scand. 116:1982;393-402.
26. Malmstrom R.E., Balmer K.C., Lundberg J.M. The neuropeptide Y (NPY) Y-1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo. Br. J. Pharmacol. 121:1997;595-603.
27. Mangel A.W., Fitz J.G., Taylor I.L. Modulation of colonic motility by substance P, cholecystokinin and neuropeptide Y. Peptides. 12:1991;1063-1067.
28. McAuley M.A., Westfall T.C. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed. J. Pharmacol. Exp. Ther. 261:1992;863-868.
29. Modin A., Pernow J., Lundberg J.M. Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur. J. Pharmacol. 203:1991;165-171.
30. Modin A., Pernow J., Lundberg J.M. Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig. J. Auton. Nerv. Syst. 57:1996;13-21.
31. Palea S., Corsi M., Rimland J.M., Trist D.G. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein. Br. J. Pharmacol. 115:1995;3-10.
32. Potter E.K. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci. Lett. 54:1985;117-121.
33. Potter E.K. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide Y. Neurosci. Lett. 83:1987;101-106.
34. 2) receptor. Eur. J. Pharmacol. 267:1994;253-262.
35. 34] NPY, a selective functional postjunctional agonist at neuropeptide-Y receptors in anaesthetised rats. Neurosci. Lett. 134:1992;183-186.
36. Revington M.L., Lacroix J.S., Potter E.K. Sympathetic and parasympathetic interaction in vascular and secretory control of the nasal mucosa in anaesthetized dogs. J. Physiol. 505:1997;823-831.
37. Revington M.L., Potter E.K., McCloskey D.I. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats. J. Physiol. 431:1990;495-503.
38. 4) receptor. Peptides. 19:1998;537-542.
39. Tobin G., Luts A., Sundler F., Ekstrom J. VIP-containing nerve fibres in the submandibular gland of the dog and protein secretion in vitro in response to VIP. Regul. Pept. 29:1990;173-177.
40. Wahlestedt C., Yanaihara N., Hakanson R. Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept. 13:1986;307-318.
41. Warner M.R., Levy M.N. Neuropeptide Y as a putative modulator of the vagal effects on heart rate. Circ. Res. 64:1989;882-889.